Roche, a Swiss healthcare giant with global reach, teams up with one of the leading Israeli healthcare and life sciences VC firm, aMoon, on a collaborative investment program aimed at accelerating innovative diagnostic technologies from Israel's healthtech ecosystem. The collaboration, called "StarFinder Lab," will provide funding, mentoring, and strategic support to "9 Stars," newly-formed or existing ventures, elected through the program. The partnership focuses on identifying and cultivating disruptive AI-driven data as well as digital healthcare solutions from early-stage startups providing different technological solutions for the many different moving aspects of healthcare. "Healthtech and AI are transforming the healthcare industry as we know it, and we see great value in working with Israeli healthcare innovators as they build their companies," said Michele Pedrocchi, Head of Global Strategy and Business Development at Roche Diagnostics. The joint venture will create an innovative atmosphere, where selected startups will receive access to global expertise from the Roche and aMoon.